Corium Inc.’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Corium is a commercial-stage biopharmaceutical company that develops and markets transdermal healthcare products and delivery systems. Read more

Corium is a commercial-stage biopharmaceutical company that develops and markets transdermal healthcare products and delivery systems. Read more

Perry J Sternberg's photo - President & CEO of Corium Inc.

President & CEO

Perry J Sternberg

CEO Approval Rating

89/100

Founded:

1995

Status:

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Cortexyme is one of Corium Inc.'s top rivals. Cortexyme was founded in South San Francisco, California} in 2012. Like Corium Inc., Cortexyme also competes in the Pharmaceuticals space. Compared to Corium Inc., Cortexyme generates $ less revenue.

Alzheon is Corium Inc.'s #2 competitor. Alzheon was founded in 2013, and is headquartered in Framingham, Massachusetts. Like Corium Inc., Alzheon also operates in the Pharmaceuticals space. Alzheon generates $28.5M less revenue vs. Corium Inc..

BELLUS Health is a top competitor of Corium Inc.. BELLUS Health's headquarters is in Laval, Quebec, and was founded in 1993. Like Corium Inc., BELLUS Health also works within the Pharmaceuticals sector. BELLUS Health generates 0.07% of Corium Inc.'s revenue.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 213 a good estimate for Corium Inc.'s Employee count?

Acquisitions

No recent acquisitions found related to Corium Inc.

Corium Inc. Funding History

$52M

Since Corium Inc. was founded in 1995, it has participated in 1 round of funding. In total Corium Inc. has raised $52.0M. Corium Inc.'s funding round was on Apr 2014 for a total of $52.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
Apr 2014
$52M
-

Total Funding: $52M

Since Corium Inc. was founded in 1995, it has participated in 1 round of funding. In total Corium Inc. has raised $52.0M. Corium Inc.'s funding round was on Apr 2014 for a total of $52.0M

Investments

No recent investments found related to Corium Inc.

Corium Inc. News

November 28, 2018Market Exclusive

Corium International,Inc. (NASDAQ:CORI) Files An 8-K Completion of Acquisition or Disposition of Assets

The Offer and related withdrawal rights expired one minute past 11:59 pm, New York City time, on Nove... See more »
November 27, 2018BioPortfolio

Gurnet Point Capital Completes Tender Offer for Corium International Transaction Valued in Excess of $500 Million

Gurnet Point Capital Gurnet Point a private investment firm focused on the healthcare and life scienc... See more »
October 15, 20184-traders

RM LAW Announces Investigation of Corium International, Inc.

(marketscreener.com) BERWYN, Pa., Oct. 15, 2018 /PRNewswire/ -- RM LAW, P.C. is investigating potenti... See more »
October 12, 201824/7 Wall St.

Why Corium Shares Are Booming

October 12, 2018MarketWatch

Corium's stock rockets to pace premarket gainers after Gurnet buyout deal

Share of Corium International Inc. rocketed 50.7% to pace all premarket gainers Friday, after the bio... See more »
October 12, 2018Market Exclusive

Corium International,Inc. (NASDAQ:CORI) Files An 8-K Entry into a Material Definitive Agreement

On October11, 2018, Corium International,Inc., a Delaware corporation (the “Company”), entered into a... See more »
October 11, 20184-traders

Corium Announces Agreement for Gurnet Point Capital to Purchase All Outstanding Shares

(marketscreener.com) Total Transaction Valued in Excess of $500 Million, Representing a 50% Premium G... See more »

Corium Inc. Press Releases

June 21, 2018Business Press 24

Aequus and Corium Join Forces to Advance Anti-Nausea Transdermal Patch<br />

Aequus and Corium Join Forces to Advance Anti-Nausea Transdermal Patch Key Highlights - Aequus and Co... See more »
May 14, 2018GlobeNewswire

Corium Reports Second Quarter Fiscal 2018 Financial Results and Corporate Highlights

MENLO PARK, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a comm... See more »
December 29, 2017MarketersMedia

Free Research Report as Corium's Revenue Grew 19.2%

LONDON, UK / ACCESSWIRE / December 29, 2017 / Active-Investors.com has just released a free earnings ... See more »
December 12, 2017GlobeNewswire

Corium to Join NASDAQ Biotechnology Index

MENLO PARK, Calif., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a com... See more »
November 16, 2017MarketersMedia

Corium International, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / November 16, 2017 / Corium International, Inc. (NASDAQ: CORI) will be dis... See more »
November 16, 2017EconoTimes

Corium Reports Fourth Quarter and Fiscal Year 2017 Financial Results and Corporate Highlights

Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the... See more »
September 5, 2017GlobeNewswire

Corium to Present at Upcoming Healthcare Conferences

MENLO PARK, Calif., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a co... See more »

Headquarters

235 Constitution Drive

Menlo Park, California94025

650-298-8255

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Corium is a commercial-stage biopharmaceutical company that develops and markets transdermal healthcare products and delivery systems. Corium Inc. was founded in 1995. Corium Inc.'s headquarters is located in Menlo Park, California, USA 94025. It has ...

CEO

Corium Inc.'s President & CEO, Perry J Sternberg, currently has an approval rating of 89%. Corium Inc.'s primary competitors are Cortexyme, Alzheon & BELLUS Health.

Website

coriumintl.com

Frequently Asked Questions about Corium Inc.

  1. When was Corium Inc. founded?

    Corium Inc. was founded in 1995
  2. Who is Corium Inc.'s CEO?

    Corium Inc.'s CEO is Perry J Sternberg
  3. How much revenue does Corium Inc. generate?

    Corium Inc. generates $36.5M in revenue
  4. How much funding does Corium Inc. have?

    Corium Inc. has historically raised $52M in funding
  1. Where is Corium Inc.'s headquarters?

    Corium Inc.'s headquarters is in Menlo Park California, USA
  2. How many employees does Corium Inc. have?

    Corium Inc. has 213 employees
  3. What sector does Corium Inc. operate in?

    Corium Inc. is in Pharmaceuticals
  4. Who are Corium Inc.'s competitors?

    Corium Inc.'s top competitors are Cortexyme, Alzheon, BELLUS Health